# Cintrifuse

> Cintrifuse is a VC fund in Cincinnati backing Advertising and Health Care. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cincinnati, United States
- Total investments: 6
- Last investment: Jun 2024
- Lead investor: 0%
- Fund size: $56M
- Last fund: Jul 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/2959452/
- X (Twitter): http://twitter.com/cintrifuse
- Website: https://www.cintrifuse.com
- Facebook: https://www.facebook.com/cintrifuse

Cintrifuse is a Cincinnati-based organization that proactively links entrepreneurs with strategic businesses, research institutions, mentors and investors to help successfully launch high-growth startups. We work to coordinate the activities, resources and programs of the region’s innovation ecosystem by connecting incubators, accelerators,investment sources, organizations and other resources to maximize information sharing. We have harnessed three core elements to develop a sustainable innovation economy: Access, Place and Fund

## Contacts

5 contacts available for Cintrifuse. Shizune tracks 8 team members at Cintrifuse. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cintrifuse?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Advertising | 1 | 17% |
| Health Care | 1 | 17% |
| Construction | 1 | 17% |
| Life Science | 1 | 17% |
| Manufacturing | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Series A | 2 | 33% |
| Series B | 1 | 17% |
| Series C | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric Weissmann | Director of Marketing | 0 | — |
| Pete Blackshaw | Chief Executive Officer | 0 | — |
| Eric Fulkert | Mentor - Advisor network | 0 | — |
| Henry Molski | Marketing & PR Manager | 0 | — |
| Jessica Boesch | Project Coordinator | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LunchTable | LunchTable is the fan activation platform that transforms casual fans into a loyal army of brand ambassadors through targeted campaigns, and data-driven strategies for brand interaction. It provides marketing strategies, and advertisements for brand promotion. | $2.4M | Seed | Jun 18, 2024 |  |
| Cloverleaf.me | Cloverleaf improves team dynamics by integrating disconnected HR data and insights into personalized, actionable development experiences at scale. Cloverleaf enables personalized coaching, clearer communication, and stronger team alignment throughout the entire employee lifecycle. Built upon validated behavioral assessments and real-timeperformance insights, Cloverleaf empowers managers and teams to collaborate effectively, resolve challenges proactively, and unlock greater human potential. Trusted by more than 30,000 teams, Cloverleaf helps organizations create cohesive, aligned teams, improving employee performance, engagement, and productivity. For more information, visit cloverleaf.me. | $7.3M | Series A | Mar 27, 2024 |  |
| Enable Injections | Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators. | $215M | Series C | Jan 27, 2022 |  |
| Struxtion | Struxtion provides undeserved commercial construction contractors. | $5.5M | Seed | Nov 01, 2021 |  |
| Enable Injections | Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators. | $50M | Series B | Oct 25, 2018 |  |
| Enable Injections | Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators. | $30M | Series A | Oct 05, 2016 |  |

6 of 6 investments shown.

## Co-investors
- [CincyTech](https://shizune.co/investors/profile/cincytech) — VC Fund, 3 deals together
- [Ohio Innovation Fund](https://shizune.co/investors/profile/ohio-innovation-fund) — VC Fund, 3 deals together
- [Cincinnati Children’s](https://shizune.co/investors/profile/cincinnati-childrens) — VC Fund, 2 deals together
- [ORI Capital](https://shizune.co/investors/profile/ori-capital) — VC Fund, 2 deals together
- [Partisan Management Group](https://shizune.co/investors/profile/partisan-management-group) — VC Fund, 2 deals together
- 1809 Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cintrifuse invest in?

Cintrifuse invests primarily in Advertising, Health Care and Construction startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cintrifuse?

Public channels for Cintrifuse include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cintrifuse?

The team at Cintrifuse includes Eric Weissmann (Director of Marketing), Pete Blackshaw (Chief Executive Officer) and Eric Fulkert (Mentor - Advisor network), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co